Functional subsets of tumor-specific CD8 T cells in draining lymph nodes and tumor microenvironment.

Curr Opin Immunol

Institute of Immunology, Third Military Medical University, Chongqing, China. Electronic address:

Published: November 2024

AI Article Synopsis

  • Tumor-specific CD8 T cells in lymph nodes associated with tumors (TdLNs) act as a source of exhausted T cell types within the tumor microenvironment, including progenitor exhausted T cells and new memory T cell subsets.
  • These two subsets play a key role in enhancing the effects of PD-1/PD-L1 immune checkpoint blockade (ICB) by working together over time and space.
  • While ICB treatment boosts the growth and differentiation of these T cell subsets, it does not prevent them from eventually becoming terminally exhausted, which may contribute to the frequent relapses seen in patients after initial treatment.

Article Abstract

Accumulating evidence demonstrates that tumor-specific CD8 T cells in tumor-draining lymph nodes (TdLNs) act as an upstream reservoir of exhausted subsets within tumor microenvironment (TME). This reservoir primarily consists of progenitor exhausted CD8 T (T) cells and newly defined tumor-specific memory subsets (T). We propose that these two subsets work together to mediate the antitumor effects of PD-1/PD-L1 immune checkpoint blockade (ICB) in a spatiotemporal manner. Although PD-1/PD-L1 ICB monotherapy drives the proliferation and further differentiation of these subsets, it does not alter the programmed differentiation trajectory from T cells to T cells, ultimately leading to the development of terminally exhausted CD8 T cells. This phenomenon may partly explaining the frequent relapse in patients following initial ICB therapy. In this review, we focus on the phenotypic and functional heterogeneity of tumor-specific CD8 T cells in both TdLNs and the TME and discuss the implications of these studies for ICB. Our insights aim to illuminate new strategies for advancing tumor immunotherapies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2024.102506DOI Listing

Publication Analysis

Top Keywords

cd8 cells
20
tumor-specific cd8
12
lymph nodes
8
tumor microenvironment
8
exhausted cd8
8
cells
7
cd8
5
functional subsets
4
tumor-specific
4
subsets tumor-specific
4

Similar Publications

Background: Tumor microenvironment (TME) plays a crucial role in tumor growth and metastasis. Exploring biomarkers that are significantly associated with TME can help guide individualized treatment of patients.

Methods: We analyzed the expression and survival of P4HB in pan-cancer through the TCGA database, and verified the protein level of P4HB by the HPA database.

View Article and Find Full Text PDF

Immunomodulatory insights of monoterpene glycosides in endometriosis: immune infiltration and target pathways analysis.

Hereditas

January 2025

Emergency Department, Ningbo Municipal Hospital of Traditional Chinese Medicine, Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, Zhejiang Province, China.

Endometriosis is a complex gynecological condition characterized by abnormal immune responses. This study aims to explore the immunomodulatory effects of monoterpene glycosides from Paeonia lactiflora on endometriosis. Using the ssGSEA algorithm, we assessed immune cell infiltration levels between normal and endometriosis groups.

View Article and Find Full Text PDF

New treatment approaches are warranted for patients with advanced melanoma refractory to immune checkpoint blockade (ICB) or BRAF-targeted therapy. We designed BNT221, a personalized, neoantigen-specific autologous T cell product derived from peripheral blood, and tested this in a 3 + 3 dose-finding study with two dose levels (DLs) in patients with locally advanced or metastatic melanoma, disease progression after ICB, measurable disease (Response Evaluation Criteria in Solid Tumors version 1.1) and, where appropriate, BRAF-targeted therapy.

View Article and Find Full Text PDF

The forward design of biosensors that implement Boolean logic to improve detection precision primarily relies on programming genetic components to control transcriptional responses. However, cell- and gene-free nanomaterials programmed with logical functions may present lower barriers for clinical translation. Here we report the design of activity-based nanosensors that implement AND-gate logic without genetic parts via bi-labile cyclic peptides.

View Article and Find Full Text PDF

Early therapeutic intervention in high-risk smoldering multiple myeloma (HR-SMM) has shown benefits, however, no studies have assessed whether biochemical progression or response depth predicts long-term outcomes. The single-arm I-PRISM phase II trial (NCT02916771) evaluated ixazomib, lenalidomide, and dexamethasone in 55 patients with HR-SMM. The primary endpoint, median progression-free survival (PFS), was not reached (NR) (95% CI: 57.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!